<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9072">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05705830</url>
  </required_header>
  <id_info>
    <org_study_id>2022-0704</org_study_id>
    <nct_id>NCT05705830</nct_id>
  </id_info>
  <brief_title>A Multicenter Randomized Controlled Study of Pulse Magnetotherapy Combined Medication in Anxiety Combined With Insomnia</brief_title>
  <official_title>A Multicenter Randomized Controlled Study of Pulse Magnetotherapy Combined Medication in the Treatment of Patients With Anxiety Disorder and Insomnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical trial is to explore the therapeutic effect of pulse magnetic&#xD;
      therapy system combined with drug therapy on patients with anxiety and insomnia. The main&#xD;
      questions it aims to answer are:&#xD;
&#xD;
        1. Whether the pulse magnetic therapy system is benefit on improving insomnia in anxiety&#xD;
           patients.&#xD;
&#xD;
        2. This improvement is not due to the placement of the instrument。 Participants will accept&#xD;
           pulse magnetic therapy (stimulation/sham stimulation) and accept scale evaluation before&#xD;
           and after treatment.&#xD;
&#xD;
      Researchers will compare the pulse magnetic stimulation group, sham stimulation group and&#xD;
      healthy controls to see if the pulse magnetic stimulation do effect on insomnia of anxiety&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Insomnia is the most common symptom of anxiety disorder, which has an important impact on the&#xD;
      prognosis of anxiety. Pulse magnetic therapy system, with its advantages of compact,&#xD;
      convenient, easy to carry, and not limited by the scene and time, has gradually become a&#xD;
      common tool for sleep monitoring and treatment. This study is a multicenter randomized&#xD;
      controlled design, including 150 cases in the pulse magnetic stimulation+drug treatment&#xD;
      group, 150 cases in the sham pulse magnetic stimulation+drug treatment group and 100 healthy&#xD;
      controls. Before and after treatment, the patients were comprehensively measured and&#xD;
      evaluated with Insomnia Severity Index (ISI), Hamilton Depression Rating Scale 17 (HAMD),&#xD;
      Hamilton Anxiety Rating Scale (HAMA), Pittsburgh Sleep Quality Index (PSQI), Self-Rating&#xD;
      Sleep Scale (SSRS), Self-Rating Symptom Scale 90 (SCL-90), Quality of Life Scale (SF-36), and&#xD;
      Treatment Adverse Reaction Scale (TESS), and sleep monitoring was conducted at the same time,&#xD;
      To explore the therapeutic effect of pulse magnetic therapy system detector combined with&#xD;
      drug therapy on patients with anxiety and insomnia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2022</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insomnia Severity Index (ISI)</measure>
    <time_frame>Change value of insomnia severity index (ISI) from baseline in the fourth week of intervention</time_frame>
    <description>Insomnia Severity Index total score reduction&gt;50%, the range of Insomnia Severity Index total score is 0-28.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Anxiety Disorder</condition>
  <condition>Insomnia</condition>
  <arm_group>
    <arm_group_label>Pulse Magnetotherapy+medication group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>150 patients with anxiety disorder and insomnia who met the inclusion criteria received pulse magnetic therapy and conventional antianxiety drugs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medication group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>150 patients with anxiety disorder and insomnia who met the inclusion criteria received sham magnetic therapy and conventional antianxiety drugs</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>100 healthy controls who met the inclusion criteria received sham magnetic therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pulse magnetic therapy</intervention_name>
    <description>Pulse magnetic therapy SM-II (2019102133903)</description>
    <arm_group_label>Pulse Magnetotherapy+medication group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Selective serotonin reuptake inhibitors （SSRI）</intervention_name>
    <description>Anti-anxiety Drugs</description>
    <arm_group_label>Pulse Magnetotherapy+medication group</arm_group_label>
    <arm_group_label>medication group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Shame magnetic therapy</intervention_name>
    <description>Shame magnetic therapy</description>
    <arm_group_label>Healthy control</arm_group_label>
    <arm_group_label>medication group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patients who met the diagnostic criteria for anxiety disorder in the Diagnostic and&#xD;
             Statistical Manual of Mental Disorders (Fifth edition; DSM-5) and were accompanied by&#xD;
             insomnia with 14 &lt;HAMA&lt;21 , HAMD&lt;17 , and PSQI&gt;7 ;&#xD;
&#xD;
          2. Education level is unlimited;&#xD;
&#xD;
          3. Age: 18-55 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Have bipolar disorder, schizophrenia, depression and other mental diseases;&#xD;
&#xD;
          2. Have a clear history of head trauma, alcoholism, brain tumors, diabetes, hypertension,&#xD;
             and serious primary heart, liver, kidney, and blood system diseases;&#xD;
&#xD;
          3. At present, patients with sleep disorders are being treated by other means besides&#xD;
             drugs;&#xD;
&#xD;
          4. Pregnant and lactating women;&#xD;
&#xD;
          5. Have a history of seizures or strong positive family history of epilepsy;&#xD;
&#xD;
          6. Implantation of cardiac pacemaker;&#xD;
&#xD;
          7. Those receiving deep brain stimulation treatment;&#xD;
&#xD;
          8. There are metal or magnetic implants in the body (including but not limited to the&#xD;
             brain);&#xD;
&#xD;
          9. Participated in clinical trials of other drugs and medical devices in recent 3 months;&#xD;
&#xD;
         10. Other researchers believe that they do not meet the conditions for inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zheng Lin</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zheng Lin, Doctor</last_name>
    <phone>86-13757118261</phone>
    <email>Linzzr@126.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Changxing County People's Hospita</name>
      <address>
        <city>Changxing</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tao Yan, Master</last_name>
      <phone>86-13957258775</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Linping First People's Hospital</name>
      <address>
        <city>Linping</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuze Sheng, Master</last_name>
      <phone>86-15990077882</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Fourth Affiliated Hospital of Zhejiang University School of medicine</name>
      <address>
        <city>Yiwu</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunrong Lu, Doctor</last_name>
      <phone>86-13757118257</phone>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2022</verification_date>
  <study_first_submitted>October 25, 2022</study_first_submitted>
  <study_first_submitted_qc>January 30, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 31, 2023</study_first_posted>
  <last_update_submitted>February 15, 2023</last_update_submitted>
  <last_update_submitted_qc>February 15, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anxiety</keyword>
  <keyword>Insomnia</keyword>
  <keyword>Pulse Magnetotherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Initiation and Maintenance Disorders</mesh_term>
    <mesh_term>Anxiety Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Serotonin</mesh_term>
    <mesh_term>Selective Serotonin Reuptake Inhibitors</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

